METHOD FOR SECRETING THROMBOPOIETIN POLYPEPTIDES

(19)

(11)

EP 0 799 317 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	07.06.2006 Bulletin 2006/23

(45)	Mention of the grant of the patent:
	28.04.2004 Bulletin 2004/18

(21)	Application number: 95944594.1

(22)	Date of filing: 15.11.1995

(51)

International Patent Classification (IPC):

C12N 15/62^(1990.01)
C12N 15/19^(1990.01)
C12N 5/10^(1990.01)

C07K 14/52^(1995.01)
C12N 1/19^(1990.01)
C12N 15/58^(1990.01)

(86)	International application number:
	PCT/US1995/014932

(87)	International publication number:
	WO 1996/017067 (06.06.1996 Gazette 1996/26)

(54)	METHOD FOR SECRETING THROMBOPOIETIN POLYPEPTIDES VERFAHREN ZUR SEKRETION THROMBOPOITIN POLYPEPTIDE PROCEDES CONCERNANT LA SECRETION DE POLYPEPTIDES DE THROMBOPOIETINE

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

30.11.1994 US 347029

(43)	Date of publication of application:
	08.10.1997 Bulletin 1997/41

(73)	Proprietor: ZymoGenetics, Inc.
	Seattle, WA 98102 (US)

(72)	Inventors:
	FOSTER, Donald, C. Seattle, WA 98155 (US) HEIPEL, Mark, D. Seattle, WA 98117 (US) HOLLY, Richard, D. Seattle, WA 98177 (US)

(74)	Representative: Bizley, Richard Edward et al
	HLBBshaw Merlin House Falconry Court Baker's Lane Epping, Essex CM16 5DQ Epping, Essex CM16 5DQ (GB)

(56)

References cited: :

EP-A- 0 486 193

NATURE, vol. 369, 16 June 1994 pages 565-568, S. LOK ET AL 'Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo'
FEBS LETTERS, vol. 353, 10 October 1994 pages 57-61, Y. SOHMA ET AL 'Molecular cloning and chromosomal localization of the human thrombopoietin gene'

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).